| ABIVAX SA SP.ADR O.N. |
| USA |
| Gesundheit |
| US00370M1036 / A3EWCP |
| 2X10 (Frankfurt) / ABVX (NASDAQ) |
| FRA:2X10, ETR:2X10, 2X10:GR, NASDAQ:ABVX |
| - |
| https://www.abivax.com/ |
|
Abivax S.A. American Depositary Receipt represents shares in Abivax SA, a clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms, particularly through enhanced expression of micro..
>Volltext.. |
| 7946.28 Mio. EUR |
| 7445.11 Mio. EUR |
| - |
| -243.27 Mio. EUR |
| -329.37 Mio. EUR |
| -4.63 EUR |
| 32.28 Mio. EUR |
| 519.67 Mio. EUR |
| -157.26 Mio. EUR |
| 8.42 |
| - |
| -296.6% |
| - |
| - |
| - |
| - |
| ABIVAX ADR, ABIVAX |
| 08.04.26 |
|